Back to PRIM&R Home ConferenceHeader
  • Keynote Speakers

    March 20, 8:30-9:15 AM

    Kathleen R. Pritchett-Corning, DVM, DACLAM
    Senior Clinical Veterinarian, Harvard University Faculty of Arts and Sciences; Affiliate Assistant Professor, Department of Comparative Medicine, University of Washington

    Kathleen R. Pritchett-Corning, DVM, DACLAM, is a senior clinical veterinarian at the Harvard University Faculty of Arts and Sciences, and an affiliate assistant professor in the Department of Comparative Medicine at the University of Washington. She has more than 20 years' experience in laboratory animal science and medicine, with a focus on animal-based husbandry research. Dr. Pritchett-Corning received her BS and DVM from Washington State University, and she completed her post-doctoral training in laboratory animal medicine at the University of Washington. She has authored more than 60 peer-reviewed publications and book chapters, including chapters in Laboratory Animal Medicine (3rd edition, Elsevier, 2015) and five volumes of the Charles River Handbook series. Dr. Pritchett-Corning received the American Association for Laboratory Animal Science (AALAS) Pravin Bhatt Scientific Excellence Award in 2015. She is a member of the Laboratory Animal Working Group of the American Veterinary Medical Association (AVMA) Panel on Euthanasia and the AVMA Panel on Depopulation, as well as a member of the Federation for Laboratory Animal Science Associations (FELASA) Working Group on Health Monitoring, and the joint AALAS/FELASA Working Group on Health Monitoring of Rodents for Animal Transfer. Dr. Pritchett-Corning has held positions at the University of Washington, the Jackson Laboratory, and Charles River Laboratories. Dr. Pritchett-Corning will give this year's Henry Spira Memorial Lecture.

    March 20, 2:00-2:45 PM

    Jerrold Tannenbaum, JD
    Professor Emeritus, University of California, Davis School of Veterinary Medicine

    Jerrold Tannenbaum, JD, is professor emeritus at the University of California (UC), Davis School of Veterinary Medicine, where he taught required courses in veterinary law and ethics from 1999 to 2013. In addition, Professor Tannenbaum taught these subjects for 17 years at Tufts University School of Veterinary Medicine, where he helped to found that school's signature program in Ethics and Values and its Masters Program in Animals and Public Policy. At UC Davis, he also taught an undergraduate course in animal ethics for animal science and animal biology students for eight years and, from 2003 to 2015, offered the first course in animal law at the UC Davis School of Law. His recent publications include: "What is Animal Law?", Cleveland State Law Review (Vol. 61, No. 4, December 2013); "Russell and Burch's 3Rs Then and Now: The Need for Clarity in Definition and Purpose" (with B. Taylor Bennett), Journal of the American Association for Laboratory Animal Science (Vol. 54 No. 2, March 2015); "Ethics in the Use of Animal Models of Seizures and Epilepsy" (chapter), in A. Pitkänen, P.S. Buckmaster, A.S. Galanopoulou, and S.L Moshé (editors), Models of Seizure and Epilepsy (2nd edition, Academic Press, 2017); and "Ethics in Biomedical Animal Research: The Key Role of the Investigator" (chapter), in P. Michael Conn (editor), Animal Models for the Study of Human Disease (2nd edition, Academic Press, 2017). Mr. Tannenbaum did his undergraduate work in philosophy at Cornell University, his graduate work in philosophy at The Rockefeller University and Cornell University, and he was an assistant professor of philosophy at UC Santa Barbara. In addition, he is a graduate of Harvard Law School, and was an assistant district attorney in New York County (Manhattan), New York.

    March 21, 8:15-9:00 AM

    Martin K. (Casey) Childers, DO, PhD
    Professor, Department of Rehabilitation Medicine; Co-Director, Institute for Stem Cell and Regenerative Medicine, University of Washington

    Martin ChildersMartin K. (Casey) Childers, DO, PhD, is a professor in the Department of Rehabilitation Medicine, and co-director of the Institute for Stem Cell and Regenerative Medicine at the University of Washington. He is a graduate of Seattle Pacific University (BA, music performance), Western University (DO, medicine, osteopathic), and the University of Missouri (PhD, physiology and pharmacology; residency, rehabilitation medicine). The Childers' Laboratory works in two areas of investigation: in preclinical studies, they address issues related to systemic gene replacement delivery for patients with rare neuromuscular diseases, such as X-Linked Myotubular Myopathy and, in other studies, they use a "disease in a dish" approach with induced pluripotent stem cells to study heart disease in patients with Duchenne muscular dystrophy. Dr. Childers' clinical medicine practice at the University of Washington Medical Center is dedicated to serve patients with neuromuscular diseases.

    Alison Rockett Frase
    President, Joshua Frase Foundation

    Alison FraseAlison Rockett Frase is the president of the Joshua Frase Foundation. Once the assistant personnel manager for a leading rock and roll band, she is now the driving force behind this organization. In 1995, Ms. Frase gave birth to her son, Joshua—a baby so weak, he could only move his right hand. The doctors said he wouldn’t survive the day and, from that moment, Ms. Frase became Joshua’s advocate and, in 1996, together with her husband, she created the Joshua Frase Foundation. Since that time, Ms. Frase has helped raise nearly $7 million to fund medical research, search for a cure, and raise awareness of neuromuscular-related disorders. As president of the Foundation, Ms. Frase assumes the role of patient advocate, marketer, public relations manager, event planner, and administrator. In addition to raising funds for medical research and building an increased awareness of neuromuscular disorders in children, she has created a network support system for affected families and clinicians dealing with neuromuscular disorders. Through this network and her website, she is able to reach out to other families worldwide who deal with the day-to-day care needed to enhance the lives of these children, provides resources and information pertinent to the disease, and options and strategies to overcome the unique challenges these disorders can present. It is important to note that Ms. Frase did all of this while caring for her son, who required 24-hour care. Today, she continues her work in memory of her son, who passed away on Christmas Eve, 2010. Her passion has shifted from finding a cure for her son to finding a cure for other children affected with this disorder, so no parent has to suffer what she now faces every day—the blinding pain of losing a child. In 2015, Ms. Frase was awarded the RARE Champion of Hope Advocacy Award by Global Genes. She launched the international Family Registry for Centronuclear and Myotubular Myopathies in 2012 (this registry is now a member of the NIH/National Center for Advancing Translational Science Global Rare Diseases Registry Data Repository® program), and she is serving on the access to data committee as a patient advocacy representative.